Review



promis-ii cohort  (ProMIS Neurosciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ProMIS Neurosciences promis-ii cohort
    Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts
    Promis Ii Cohort, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/promis-ii+cohort/promis+ii+cohort/pmc06499490-318-17-17
    Average 90 stars, based on 1 article reviews
    promis-ii cohort - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients"

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients

    Journal: Health psychology : official journal of the Division of Health Psychology, American Psychological Association

    doi: 10.1037/hea0000679

    Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts
    Figure Legend Snippet: Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts

    Techniques Used: Biomarker Discovery

    Model selection indices comparing 1, 2, 3 and 4 PRO latent profile models
    Figure Legend Snippet: Model selection indices comparing 1, 2, 3 and 4 PRO latent profile models

    Techniques Used: Selection

    Latent profile assignment probabilities using the three-category profile LPA models in the PROMIS-II and NEPTUNE cohorts
    Figure Legend Snippet: Latent profile assignment probabilities using the three-category profile LPA models in the PROMIS-II and NEPTUNE cohorts

    Techniques Used:

    Related Articles

    Biomarker Discovery:

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: Entropy statistics were equally strong in the pediatric (0.91) and adult (0.88) NEPTUNE samples compared to the PROMIS-II cohort (0.87).

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: Additionally, the PROMIS-II cohort showed higher degrees of proteinuria than the NEPTUNE pediatric cohort (median urine protein: creatinine ratio [g/g] 5.2 [IQR=2.2, 8.6] vs. 2.6 [1.6, 7.3], p =0.02). table ft1 table-wrap mode="anchored" t5 caption a7 PROMIS-II Cohort N=121 NEPTUNE Pediatric Cohort N=40 NEPTUNE Adult Cohort N=40 Sex Male, n (%) 79 (65) 24 (60) 137 (63) Female, n (%) 42 (35) 16 (40) 82 (37) Age (years) 8-12, n (%) 65 (54) 9 (23) 0 (0) 13-17, n (%) 56 (46) 31 (77) 0 (0) ≥18, n (%) 0 (0) 0 (0) 219 (100) Race Caucasian, n (%) 64 (53) 15 (38) 132 (60) Black/African American, n (%) 33 (28) 20 (50) 31 (14) Asian, n (%) 14 (12) 1 (3) 39 (18) Other, n (%) 10 (8) 4 (10) 17 (8) Hispanic or Latino ethnicity, n (%) 10 (8) 7 (18) 27 (12) Disease duration Incident (<30 days), n (%) 56 (46) 15 (38) 72 (33) Prevalent (≥30 days), n (%) 65 (54) 25 (62) 147 (67) Urine protein: creatinine ratio (g/g), median (IQR) 5.2 (2.2, 8.6) 2.6 (1.6, 7.3) 4.1 (1.9, 6.8) eGFR ml/min/1.73m2, median (IQR) 110 (83, 134) 88 (69, 108) 65 (43, 96) Edema present, n (%) 90 (74) 14 (35) 124 (56) Diagnosis Minimal change disease, n (%) 19 (16) 12 (30) 28 (13) Focal segmental glomerulosclerosis, n (%) 19 (16) 18 (45) 69 (32) Membranous nephropathy, n (%) 1 (1) 1 (3) 57 (26) Other glomerular disease, n (%) 16 (13) 9 (23) 65 (30) Nephrotic Syndrome, not otherwise classified * , n (%) 66 (55) 0 (0) 0 (0) Open in a separate window Counts presented as n (%), Continuous variable presented as Median (Interquartile range) * In children, nephrotic syndrome is commonly treated based on clinical signs in the absence of a kidney biopsy informed diagnosis Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts PROMIS Scores Baseline PROMIS HRQOL score distributions are shown for the different cohorts in .

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: Model selection was done first using the PROMIS-II cohort and then model selection was repeated separately for the NEPTUNE pediatric and adult samples for confirmation.

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: PROMIS-II Cohort (n=121) , , , , , , , .

    Selection:

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: Entropy statistics were equally strong in the pediatric (0.91) and adult (0.88) NEPTUNE samples compared to the PROMIS-II cohort (0.87).

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: Additionally, the PROMIS-II cohort showed higher degrees of proteinuria than the NEPTUNE pediatric cohort (median urine protein: creatinine ratio [g/g] 5.2 [IQR=2.2, 8.6] vs. 2.6 [1.6, 7.3], p =0.02). table ft1 table-wrap mode="anchored" t5 caption a7 PROMIS-II Cohort N=121 NEPTUNE Pediatric Cohort N=40 NEPTUNE Adult Cohort N=40 Sex Male, n (%) 79 (65) 24 (60) 137 (63) Female, n (%) 42 (35) 16 (40) 82 (37) Age (years) 8-12, n (%) 65 (54) 9 (23) 0 (0) 13-17, n (%) 56 (46) 31 (77) 0 (0) ≥18, n (%) 0 (0) 0 (0) 219 (100) Race Caucasian, n (%) 64 (53) 15 (38) 132 (60) Black/African American, n (%) 33 (28) 20 (50) 31 (14) Asian, n (%) 14 (12) 1 (3) 39 (18) Other, n (%) 10 (8) 4 (10) 17 (8) Hispanic or Latino ethnicity, n (%) 10 (8) 7 (18) 27 (12) Disease duration Incident (<30 days), n (%) 56 (46) 15 (38) 72 (33) Prevalent (≥30 days), n (%) 65 (54) 25 (62) 147 (67) Urine protein: creatinine ratio (g/g), median (IQR) 5.2 (2.2, 8.6) 2.6 (1.6, 7.3) 4.1 (1.9, 6.8) eGFR ml/min/1.73m2, median (IQR) 110 (83, 134) 88 (69, 108) 65 (43, 96) Edema present, n (%) 90 (74) 14 (35) 124 (56) Diagnosis Minimal change disease, n (%) 19 (16) 12 (30) 28 (13) Focal segmental glomerulosclerosis, n (%) 19 (16) 18 (45) 69 (32) Membranous nephropathy, n (%) 1 (1) 1 (3) 57 (26) Other glomerular disease, n (%) 16 (13) 9 (23) 65 (30) Nephrotic Syndrome, not otherwise classified * , n (%) 66 (55) 0 (0) 0 (0) Open in a separate window Counts presented as n (%), Continuous variable presented as Median (Interquartile range) * In children, nephrotic syndrome is commonly treated based on clinical signs in the absence of a kidney biopsy informed diagnosis Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts PROMIS Scores Baseline PROMIS HRQOL score distributions are shown for the different cohorts in .

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: Model selection was done first using the PROMIS-II cohort and then model selection was repeated separately for the NEPTUNE pediatric and adult samples for confirmation.

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients
    Article Snippet: PROMIS-II Cohort (n=121) , , , , , , , .



    Similar Products

    promis-ii cohort  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences promis-ii cohort
    Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts
    Promis Ii Cohort, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/promis-ii+cohort/promis+ii+cohort/pmc06499490-318-17-17
    Average 90 stars, based on 1 article reviews
    promis-ii cohort - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    promis-ii and neptune pediatric combined cohort  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences promis-ii and neptune pediatric combined cohort
    Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts
    Promis Ii And Neptune Pediatric Combined Cohort, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/promis-ii+cohort/promis+ii+and+neptune+pediatric+combined+cohort/pmc06499490-70-0-0
    Average 90 stars, based on 1 article reviews
    promis-ii and neptune pediatric combined cohort - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts

    Journal: Health psychology : official journal of the Division of Health Psychology, American Psychological Association

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients

    doi: 10.1037/hea0000679

    Figure Lengend Snippet: Baseline demographic and clinical characteristics of the PROMIS-II and NEPTUNE cohorts

    Article Snippet: Entropy statistics were equally strong in the pediatric (0.91) and adult (0.88) NEPTUNE samples compared to the PROMIS-II cohort (0.87).

    Techniques: Biomarker Discovery

    Model selection indices comparing 1, 2, 3 and 4 PRO latent profile models

    Journal: Health psychology : official journal of the Division of Health Psychology, American Psychological Association

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients

    doi: 10.1037/hea0000679

    Figure Lengend Snippet: Model selection indices comparing 1, 2, 3 and 4 PRO latent profile models

    Article Snippet: Entropy statistics were equally strong in the pediatric (0.91) and adult (0.88) NEPTUNE samples compared to the PROMIS-II cohort (0.87).

    Techniques: Selection

    Latent profile assignment probabilities using the three-category profile LPA models in the PROMIS-II and NEPTUNE cohorts

    Journal: Health psychology : official journal of the Division of Health Psychology, American Psychological Association

    Article Title: Using PROMIS ® to create clinically meaningful profiles of nephrotic syndrome patients

    doi: 10.1037/hea0000679

    Figure Lengend Snippet: Latent profile assignment probabilities using the three-category profile LPA models in the PROMIS-II and NEPTUNE cohorts

    Article Snippet: Entropy statistics were equally strong in the pediatric (0.91) and adult (0.88) NEPTUNE samples compared to the PROMIS-II cohort (0.87).

    Techniques: